Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bypassing Agents with Tranexamic Acid in Hemophilia A
NCT01800435Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Oct 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in hemophilia A, sponsored by Oslo University Hospital. Started Oct 2011; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01800435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01800435.